The nine compounds in this category span a structural range: peptide single agonists (semaglutide, liraglutide), peptide dual agonists (tirzepatide for GIP/GLP-1
There are no established conclusions regarding human safety, pharmacokinetics, dosing, or therapeutic applications, and all observations remain within the scope of ongoing scientific investigation
(2020) presented convincing evidence that elevated TMAO in CVDs could result from the disease-related imbalance in gut microbiota but not the cause of CVDs (Huc et al., 2018)
Studies have shown that oil pulling reduces oral microbial count, thereby preventing caries and halitosis (235)
Cagrilintide showed similar directional improvements, though the magnitude was generally proportional to the degree of weight loss rather than suggesting independent cardiovascular effects
The Phase 3 lipodystrophy trials Tesamorelins approval rests on two Phase 3 double-blind, placebo-controlled randomized trials (plus their pooled analyses) in patients with HIV-associated lipodystrophy